SOURCE: Holzer Holzer & Fistel, LLC

Holzer Holzer & Fistel, LLC

November 12, 2009 10:28 ET

Holzer Holzer & Fistel, LLC Announces That It Has Filed a Class Action Lawsuit on Behalf of Investors in Hemispherx Biopharma, Inc.

ATLANTA, GA--(Marketwire - November 12, 2009) - Holzer Holzer & Fistel, LLC announces that it has filed a class action lawsuit in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Hemispherx Biopharma, Inc. ("Hemispherx" or the "Company") (AMEX: HEB) who purchased shares between February 18, 2009 and October 30, 2009, inclusive (the "Class Period"). The lawsuit alleges that Hemispherx misrepresented the status of its experimental drug Ampligen. Specifically, the complaint alleges that, among other things, the Company failed to disclose that requests for information from the Food and Drug Administration would delay possible FDA approval of Ampligen by at least several months.

If you purchased shares of Hemispherx common stock during the Class Period, you have the legal right to petition the Court to be appointed a "lead plaintiff." A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. Any such request must satisfy certain criteria and be made no later than January 11, 2010. Any member of the purported class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. If you are a Hemispherx investor and would like to discuss a potential lead plaintiff appointment, or your rights and interests with respect to the lawsuit, you may contact Michael I. Fistel, Jr., Esq., or Marshall P. Dees, Esq. via email at, or, or via toll-free telephone at (888) 508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, and upon request from the firm.